These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9472698)

  • 1. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM
    Carcinogenesis; 1998 Jan; 19(1):87-91. PubMed ID: 9472698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
    Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.
    Mahmoud NN; Bilinski RT; Churchill MR; Edelmann W; Kucherlapati R; Bertagnolli MM
    Cancer Res; 1999 Jan; 59(2):353-9. PubMed ID: 9927046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
    Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin prevents tumors in a murine model of familial adenomatous polyposis.
    Mahmoud NN; Dannenberg AJ; Mestre J; Bilinski RT; Churchill MR; Martucci C; Newmark H; Bertagnolli MM
    Surgery; 1998 Aug; 124(2):225-31. PubMed ID: 9706142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.
    Itano O; Yang K; Fan K; Kurihara N; Shinozaki H; Abe S; Jin B; Gravaghi C; Edelmann W; Augenlicht L; Kopelovich L; Kucherlapati R; Lamprecht S; Lipkin M
    Carcinogenesis; 2009 Nov; 30(11):1923-6. PubMed ID: 19755659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
    Schnitzler M; Dwight T; Robinson BG
    Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
    Mahmoud NN; Boolbol SK; Bilinski RT; Martucci C; Chadburn A; Bertagnolli MM
    Cancer Res; 1997 Nov; 57(22):5045-50. PubMed ID: 9371501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
    Winde G; Schmid KW; Brandt B; Müller O; Osswald H
    Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice.
    McEntee MF; Chiu CH; Whelan J
    Carcinogenesis; 1999 Apr; 20(4):635-40. PubMed ID: 10223192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
    Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
    Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
    Giardiello FM; Spannhake EW; DuBois RN; Hylind LM; Robinson CR; Hubbard WC; Hamilton SR; Yang VW
    Dig Dis Sci; 1998 Feb; 43(2):311-6. PubMed ID: 9512123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac.
    Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Dashwood RH
    Carcinogenesis; 2003 Feb; 24(2):263-7. PubMed ID: 12584176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac suppresses tumorigenesis in the Min mouse.
    Beazer-Barclay Y; Levy DB; Moser AR; Dove WF; Hamilton SR; Vogelstein B; Kinzler KW
    Carcinogenesis; 1996 Aug; 17(8):1757-60. PubMed ID: 8761438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.